Elite controllers or suppressors (ES) are HIV-1-infected individuals who suppress viral replication to clinically undetectable levels without antiretroviral therapy. Understanding the mechanisms by which ES control viral replication may prove informative for the design of a therapeutic vaccine. Qualitative differences in the CD8 ؉ T cell response have been implicated in control. Therefore, we isolated CD8 ؉ T cells from ES and characterized the ability of sorted memory and activation subpopulations to control viral replication at various effector-to-target cell ratios using a novel modification of a CD8 ؉ T cell suppression assay. The effector memory and terminal effector subpopulations of memory CD8 ؉ T cells had the highest inhibitory potential over the course of a 3-day in vitro infection. Interestingly, after 5 days of infection, central memory CD8
T he development of an effective vaccine against human immunodeficiency virus type 1 (HIV-1) is essential for the control of the HIV pandemic. In most HIV-1-infected individuals, known as chronic progressors (CP), high levels of viral replication lead to a progressive CD4 ϩ T cell decline over a period of 5 to 10 years in the absence of antiretroviral therapy (ART). However, a unique subset of HIV-1-infected individuals termed elite suppressors (ES) are able to maintain clinically undetectable plasma HIV-1 RNA levels (Ͻ50 RNA copies/ml) in the absence of ART for the duration of infection (6) . These remarkable individuals represent less than 1% of the HIV-1-infected population (41) . Thus, ES provide a unique opportunity to better understand the mechanisms by which durable control is achieved. While these mechanisms are unclear, an improved understanding of the immune factors that enable this remarkable control can provide guidance for the development of an effective therapeutic vaccine for HIV-1 infection.
Many studies have linked an effective cytolytic T lymphocyte response with control of HIV-1 replication. Studies in the macaque model of elite suppression have shown that depletion of CD8 ϩ T cells with monoclonal antibodies results in a loss of viral control (19, 44) . HLA-B*57 and HLA-B*5801 are overrepresented in ES (14, 21, 29, 37, 38, 45, 50) , and among HLA-B*57-positive patients, the preferential targeting of conserved HLA-B*57-restricted epitopes has been associated with control of HIV-1 replication (38) . The targeting of conserved domains in Gag has been associated with escape mutations that may lead to viral attenuation, thus facilitating control of viral replication (30, 35) . Additionally, genome-wide association studies have indicated that the HLA-B*57 and HLA-B*27 alleles are associated with viral control (9, 11, 16, 25, 32, 53) .
While some ES do not have protective HLA alleles or strong HIV-1-specific CD8 ϩ T cell responses (14, 40, 45, 49) , the HIV-1-specific CD8
ϩ T cell response in many ES has also been shown to be qualitatively more effective than the response in CP (23) . CD8 ϩ T cells from ES maintain a polyfunctional response after stimulation with HIV-1 peptides (2, 5, 17) , and there is significantly higher expression of granzyme B and perforin by HIV-1-specific CD8 ϩ T cells from ES than from CP (24, 36, 37) . In addition, CD8 ϩ T cells from ES are much more effective at suppressing HIV-1 replication in autologous CD4 ϩ T cells in vitro than CD8 ϩ T cells from CP (3, 7, 13, 37, 48, 49) , and the inhibitory potential of CD8 ϩ T cells has recently been shown to be predictive of the rate of CD4 ϩ T cell decline early in viral infection (57) . Current analysis of the CD8 ϩ T cell response in HIV-1 infection has focused primarily on unfractionated populations of CD8 ϩ T cells. However, an in vitro study showed that stimulation of CD8 ϩ T cells with HIV-1 peptides for 5 days greatly improved the inhibitory potential of these cells (37) , and a recent report suggested that a vaccine that elicits effector memory (EM) CD8 ϩ T cells was able to induce early and durable control of viral replication in simian immunodeficiency virus (SIV)-infected macaques (22) . Herein, we report a novel suppression assay in which unstimulated CD8 ϩ T cells are isolated directly ex vivo, sorted by flow cytometry into subsets based on expression of memory or activation markers, and tested for the ability to inhibit viral replication in autologous CD4 ϩ T cells. The CD4 ϩ T cells, which were not activated with antibodies or mitogens, were infected directly ex vivo and were maintained without exogenous cytokines to better recapitulate in vivo conditions. Thus, this variation of the CD8 ϩ T cell suppression assay represents the most physiological analysis of the suppressive capacity of CD8 ϩ T cells to date and the most detailed analysis of the relative inhibitory potentials of different memory and activation subsets from ES. The results provide guidance for the development of an effective cell-based vaccine against HIV-1 infection that can elicit immune responses and activation phenotypes like those observed in ES.
MATERIALS AND METHODS
Patients. All individuals provided written informed consent prior to participating in this study, and all studies were approved by the Johns Hopkins Institutional Review Board. All 8 ES maintained undetectable plasma HIV-1 RNA levels for the duration of study (Ͻ50 copies/ml) and were positive for the HLA-B*57 allele. These patients had a mean CD4 ϩ T cell count of 927/l and had been infected for an average of 14 years. The 8 CP had CD4
ϩ T cell counts ranging from 223 to 788/l (median, 391 l) and plasma HIV-1 RNA levels that ranged from 6,868 to 636,094 copies/ml (median 38,648 copies/ml). None of the CP enrolled were currently on antiretroviral therapy. Seronegative, healthy donors (HD) were 8 laboratory workers.
Isolation of CD4 ؉ and CD8 ؉ T cells. Peripheral blood mononuculear cells (PBMCs) were isolated from whole blood by Ficoll gradient separation. CD8
ϩ T cells were then purified by positive selection from PBMCs using human CD8 ϩ microbeads (Miltenyi) according to the manufacturer's guidelines. CD8
ϩ T cells were maintained in nonstimulating medium (RPMI 1640 with 10% fetal calf serum and without exogenous cytokines) on ice until cell sorting was performed. CD4 ϩ T cells were then isolated from the CD8 ϩ T cell-depleted PBMCs using human CD4 ϩ Isolation Kit II (Miltenyi) according to the manufacturer's guidelines. CD4
ϩ T cells were maintained in nonstimulating medium on ice until infection.
Healthy donor CD4
ϩ and CD8 ϩ T cells were also isolated to test for nonspecific killing in the CD8 ϩ suppression assay.
FACS. CD8
ϩ T cells from each patient were sorted into memory or activation CD8 ϩ subsets. For the memory subsets, CD8 ϩ T cells were stained with anti-CCR7-phycoerythrin (anti-CCR7-PE) (Biolegend) and anti-CD45RA-allophycocyanin (anti-CD45RA-APC) (Becton, Dickinson) antibodies by following the manufacturer's guidelines. The cells were then sorted using a FACS Aria (Becton, Dickinson) or a MoFlo (Beckman Coulter) cell sorter into the following 4 populations: naïve (N) (CCR7
, and terminal effector (TE) (CCR7 Ϫ CD45RA ϩ ) (10, 51). See Fig. 2 for a representative fluorescence-activated cell sorting (FACS) plot showing the memory cell sorting strategy. CD8 ϩ T cells were also sorted separately using anti-HLA-DR-PE (Becton, Dickinson) and anti-CD38-APC (Becton, Dickinson) antibodies according to the manufacturer's guidelines. The cells were then sorted into the following 4 populations: HLA-DR ϩ CD38 ϩ , HLA-DR Ϫ CD38 ϩ , HLA-DR Ϫ CD38 Ϫ , and HLA-DR ϩ CD38 Ϫ . After being sorted, all cells were resuspended in nonstimulating medium at a concentration of 1 ϫ 10 6 cells/ml. Cells were kept on ice until use in the CD8 ϩ suppression assay. An aliquot of bulk CD8 ϩ T cells was taken after staining and prior to cell sorting for comparison in the CD8 ϩ suppression assay. Cell purity after sorting was routinely observed to be greater than 95% for each subset (data not shown). CD8 ϩ T cells from healthy donors were also sorted for use as a negative control to test the specificity of suppression. CD4 ؉ T cell infection. CD4 ϩ T cells from each patient were infected ex vivo with a reporter virus by spinoculation at 1,200 ϫ g for 2 h at room temperature (43) . The virus used for infection, which has been routinely used by our lab group, was a replication-competent NL4-3 strain that was engineered to have green fluorescent protein (GFP) in the place of nef (NL43nGFP) (42) . CD4
ϩ T cells from all individuals were not stimulated prior to spinoculation and were subsequently cultured in nonstimulating medium. An aliquot of uninfected CD4 ϩ T cells was kept on ice to be used as a negative control. Infection of CD4 ϩ T cells was performed concurrently with the sorting of CD8 ϩ T cells. CD4 ϩ T cells from healthy donors were also infected to be used as a negative control to test the specificity of suppression.
CD8
؉ T cell suppression assay. All cells were maintained in nonstimulating medium for the duration of the experiment. All CD4 ϩ T cells and CD8 ϩ T cells were isolated, sorted, infected, and cultured on the same day. Sorted CD8 ϩ T cells (effector cells) and infected CD4 ϩ T cells (target cells) were cocultured in a 96-well plate at various effector-to-target cell (E:T) ratios. The number of CD4 ϩ T cells per well remained constant (100,000 cells per well), and the number of CD8 ϩ T cells was varied. CD8 ϩ T cells were serially diluted from a 1:1 effector-to-target cell ratio to a 1:128 effector-to-target cell ratio by 2-fold dilutions. If the number of CD8 ϩ T cells available after cell sorting was not sufficient for a 1:1 effector-to-target cell ratio, lower initial dilutions were used and 2-fold dilutions were continued to a 1:128 effector-to-target cell ratio. CD8 ϩ and CD4 ϩ cocultures were maintained in a final volume of 200 l of nonstimulating medium. Negative control wells with uninfected CD4 ϩ T cells were present on each plate. Positive control wells with infected CD4 ϩ target cells alone were also present on each plate. The percentage of infected cells in the positive controls ranged from 0.3 to 7.3 in CP versus 0.8 to 13.2 in ES and healthy donors, which is consist with our prior finding that CD4 ϩ T cells from viremic patients were relatively resistant to infection in this assay (42, 46) . Data from the inhibition assay were not used for the 4 CP in whom the infection rate of CD4 ϩ T cells was less than 1.0% or for whom there was very poor cell viability. The 4 CP whose results in the inhibition assay were not used had higher plasma HIV-1 RNA levels than the 4 CP in whom superinfection of CD4 ϩ T cells resulted in reasonable viability and infection rates (median of 297,882 versus 29,841 copies/ml).
The median percentage of infected CD4
ϩ T cells in the absence of CD8 ϩ T cells for these 4 CP was 3.6%, compared to a median of 2.9% for HD and 8.6% for ES. Each of the memory subsets (naïve, CM, EM, and TE) and the activation subsets (DR ϩ 38 ϩ , DR Ϫ 38 ϩ , DR Ϫ 38 Ϫ , and DR ϩ 38 Ϫ ) were tested individually using this suppression assay. The percent infection in each well was calculated on day 3 after infection (when GFP expression can first be reliably detected) and 2 days later for comparison. Cells were stained with anti-CD3-Pacific blue (Becton, Dickinson) and anti-CD8-APCH7 (Becton, Dickinson) antibodies to distinguish target CD4 ϩ T cells (CD3 ϩ T cell population at each effector-to-target ratio for each patient/healthy donor was calculated at day 3 and day 5. All cytometric analyses were performed using a FACS Canto II (Becton, Dickinson) and analyzed using the FACS Diva software. A minimum of 100,000 events per sample were recorded.
Intracellular cytokine staining. Cytokine production was measured by intracellular cytokine staining as previously described (3). Briefly, bulk PBMCs from each patient were isolated directly ex vivo and stimulated overnight with overlapping Gag or Nef peptide mixtures that spanned the length of each protein at a concentration of 5 g/ml. Prior to overnight incubation, cells were treated with a cocktail of anti-CD49d and anti-CD28, in addition to Golgi Plug and Golgi Stop (Becton, Dickinson) as recommended by the manufacturer. PBMCs treated in the same manner without HIV-1 peptides were analyzed to verify that the costimulatory factors alone did not result in stimulation. Cells were harvested after overnight incubation, and surface proteins were stained using anti-CD8-APCH7, anti-CCR7-PE, and anti-CD45RA-APC antibodies (Becton, Dickinson). The Cytofix/Cytoperm kit (Becton, Dickinson) was used to stain for intracellular cytokines according to the manufacturer's guidelines. Intracellular staining was performed using anti-gamma interferonPeCy7 (anti-IFN-␥-PeCy7; Becton, Dickinson) and anti-tumor necrosis factor alpha-Pacific blue (anti-TNF-␣-Pacific blue; Biolegend). Live lymphocytes were gated by forward and side scatter and then by CD8 expression, and they were then subdivided into the naïve, CM, EM, and TE CD8 ϩ T cell subsets by CCR7 versus CD45RA expression. Expression of IFN-␥ and TNF-␣ by each subset was then analyzed using an FACS Canto II (Becton, Dickinson). Data were analyzed using FACSDiva software.
Statistical analysis. For the analysis of the significance of the difference between populations, the Mann-Whitney nonparametric t test was used. P values were calculated using SPSS software, and a P value of less than 0.05 was considered significant. Significant P values are indicated on the figures. For the correlation analysis, a Pearson's correlations analysis was used. Normalized percent inhibition is shown at an E:T ratio of 1:4 since enough effectors were available at this ratio for the different subsets for all experiments. An E:T ratio of 1:32 was randomly selected for comparison.
RESULTS

CD8
؉ T cells from ES effectively inhibit viral replication. We used a novel modification of a CD8 ϩ T cell suppression assay in which CD8
ϩ T cells were isolated and assayed directly ex vivo. These unstimulated cells were cocultured at various E:T ratios with autologous, unstimulated, and freshly isolated target CD4 ϩ T cells that had been infected with replication-competent HIV-1 (NL4-3 ⌬Nef/GFP) by spinoculation. The E:T ratio ranged from 1:1 to 1:128. The percent infection for targets alone was compared to the percent infection of targets cells cultured with CD8
ϩ T cells to calculate a normalized percent inhibition for each subpopulation at each E:T ratio (Fig. 1A) . CD8 ϩ T cells from ES were markedly more effective than CD8 ϩ T cells from CP and seronegative healthy donors at each E:T ratio (Fig. 1B) . The effectiveness of CP CD8 ϩ T cells shown here is likely biased by the fact that data from CP with higher plasma HIV-1 RNA levels could not be used because of very low levels of infection and/or very poor cell viability showing the strategy used to determine the normalized percent inhibition for each CD8 ϩ T cell memory and activation subpopulation. Cells were stained with anti-CD3 and anti-CD8 antibodies to distinguish target CD4 ϩ T cells (CD3 ϩ CD8 Ϫ ) and effector CD8 ϩ T cells (CD3 ϩ CD8 ϩ ). Target cells were then gated, and the percentage of cells that were GFP positive was calculated. Uninfected target CD4 ϩ T cells were used as a negative control (left). Infected CD4 ϩ T cells cultured without CD8
ϩ T cells were used as a positive infection control (center). CD8 ϩ T cell subpopulations were cultured with infected CD4 ϩ T cells at various E:T ratios to allow the analysis of normalized percent inhibition (right). (B) Bulk CD8 T cells from HD (n ϭ 8), CP (n ϭ 4), and ES (n ϭ 8) were used in a suppression assay with E:T ratios ranging from 1:1 to 1:128. Results for HD (red line), CP (blue line), and ES (purple line) are shown, and the error bars represent the standard errors of the means.
of target cells at day 3. We would expect that CD8 ϩ T cells from these CP would be less effective at inhibiting viral replication.
The effector memory CD8 ؉ T cells are the most effective subpopulation at suppressing viral replication. To determine what memory population mediates the inhibition of viral replication in ES and CP, CD8 ϩ T cells were isolated directly from 8 ES and 8 CP and stained using anti-CCR7 and anti-CD45RA antibodies. They were then sorted using a fluorescence-activated cell sorter into previously defined (10, 51) subpopulations defined by these markers: naïve (N), central memory (CM), effector memory (EM), and terminal effector (TE) (Fig. 2A) . After 3 days of coculture, a dose-dependent relationship between the E:T ratio and the normalized percent inhibition was observed for each ES and CP population (Fig. 2B) , whereas CD8 ϩ T cells from an uninfected, healthy donor had no inhibitory effect (data not shown). The inhibition mediated by CD8 ϩ T cells from ES on day 3 was markedly higher than that mediated by CD8 ϩ T cells from CP, and an even greater level of inhibition mediated by ES CD8 ϩ T cells was observed on day 5 (Fig. 2B) .
The normalized inhibition values at E:T ratios of 1:4 and 1:32 were determined for each population. For ES, the bulk, EM, TE, and CM subsets had a significantly higher percent inhibition than did naïve CD8
ϩ T cells at a 1:4 E:T ratio. EM cells also had a significantly higher percent inhibition than did bulk and CM CD8
ϩ T cells at a 1:4 E:T ratio. Naïve CD8 ϩ T cells had little inhibitory potential at either E:T ratio. At a 1:32 E:T ratio, EM CD8 ϩ T cells caused significantly more inhibition of viral replication than did all other subpopulations and bulk CD8 ϩ T cells, and TE CD8 ϩ T cells inhibited viral replication significantly better than naïve CD8 ϩ T cells. Interestingly, differences in the patterns of inhibition by T cell subsets were observed after 5 days of coculture (Fig. 2C) . Naïve CD8 ϩ T cells showed some activity in the 5-day suppression assay, but it was relatively low compared to those of all other subtypes and bulk CD8
ϩ T cells at a 1:4 E:T ratio. The CM, TE, and EM all showed similar levels of viral suppression, but only CM CD8 ϩ T cells caused significantly higher inhibition than did bulk CD8
ϩ T cells at a 1:4 E:T ratio. At a 1:32 E:T ratio, the EM and CM subsets and bulk CD8 ϩ T cells suppressed viral replication significantly better than did naïve CD8 ϩ T cells. The percent inhibition of TE CD8 ϩ T cells was extremely variable at a 1:32 E:T ratio. The EM CD8 ϩ T cells consistently exhibited high levels of inhibition of viral replication, with a median percent inhibition of 69% at a 1:4 E:T ratio on day 3 after infection, which increased to 89% by day 5 after infection. While CM CD8 ϩ T cells were observed to have a median percent inhibition of 48% at a 1:4 E:T ratio at day 3, the median percent inhibition increased to 94% by day 5 after infection. These data indicate potent suppression of viral replication mediated by ex vivo-isolated CD8 ϩ T cells from ES. Overall, EM CD8 ϩ T had a consistent and potent inhibitory effect at E:T ratios of both 1:4 and 1:32 that was maintained on both day 3 and day 5 after infection. CM CD8 ϩ T cells, while initially producing lower inhibition than EM and TE cells, were observed to inhibit viral replication as effectively as EM CD8 ϩ T cells by day 5 after infection. Naïve CD8 ϩ T cells showed little to no inhibition of viral replication for the duration of the assay.
At a 1:4 ratio, bulk CD8 ϩ T cells from CP ( Fig. 2D) were more effective at viral inhibition than any sorted population of cells at day 3 of infection, and while all the memory subsets were more effective than naïve CD8 ϩ T cells, there was no significant difference between EM, TE, and CM cell populations. Interestingly, at a 1:32 E:T ratio, CM cells were the most effective at inhibiting viral replication. We were not able to analyze the effects of different subpopulations on viral replication at day 5 of infection because of very poor viability of the target cells at this time point, consistent with our prior observation that CD4 ϩ T cells from CP die more quickly than cells from ES and HD after superinfection (42) .
A significant change in the phenotype of ES central memory CD8
؉ T cells occurs between days 3 and 5 of infection. From day 3 to day 5 after infection, there was a dramatic increase in the percent inhibition by the ES CM CD8 ϩ T cell subpopulation (Fig.  2C) . Therefore, in a subset of the ES, the expression of CCR7 and CD45RA by the CM CD8 ϩ T cells was also analyzed on day 5 after infection to determine if there were changes in the phenotype of the cells in culture after the initial culturing of the pure, sorted CD8 ϩ T cell memory populations (Fig. 3) . CM CD8 ϩ T cells were the majority population in only one of the five ES that were analyzed. In a majority of patients, the majority cell population present was of the EM or TE phenotype. Thus, the increased suppressive ability after 5 days of infection for the sorted CM CD8
ϩ T cell population may be a result of the differentiation of CM CD8 ϩ T cells into effector CD8 ϩ T cells.
Inhibitory potential is not significantly correlated with the quantity of HIV-specific CD8
؉ T cells. It is possible that in ES, EM and TE CD8 ϩ T cells have an elevated inhibitory potential relative to the other memory subpopulations because there is a higher frequency of HIV-1-specific CD8 ϩ T cells in this subset. Therefore, to further characterize the response of the memory subtypes in HIV-1 infection, we performed a 12-h intracellular cytokine staining assay to analyze the production of cytokines by different CD8
ϩ T cells subsets after stimulation with Gag and Nef peptides. The percentages of IFN-␥, TNF-␣, and TNF-␣ and IFN-␥ dually positive cells were quantified for each memory subtype (Fig. 4A ). CM cells contained significantly more IFN-␥, TNF-␣, and dual-cytokine-secreting cells than naïve cells in response to Gag stimulation. The EM subset also contained a significantly higher fraction of cells that produced both TNF-␣ and IFN-␥ compared to naïve CD8 ϩ T cells, and the number of dualcytokine-expressing HIV-1-specific T cells was significantly higher for CM cells than for TE CD8 ϩ T cells. Similar trends were observed after stimulation with Nef peptides. The fraction of TNF-␣ and IFN-␥ dually positive cells for the CM and EM populations was significantly greater than the fraction present in the naïve subpopulation. Generally, the fraction of HIV-1-specific CD8 ϩ T cells in the EM and CM cell populations showed substantial patient-to-patient variability, and a number of patients had high levels of HIV-specific T cells in these populations. In contrast, in CP, the only significant difference in cytokine secretion seen was in TNF-␣ production: CM cells had significantly more cytokine-producing cells in response to Gag stimulation than TE and naïve cells (Fig. 4B) .
A correlation analysis was performed to determine whether there was a relationship between the frequency of HIV-1-specific CD8 ϩ T cells and inhibitory potential in each memory subset. We compared the normalized percent inhibitions for each CD8 ϩ T cell subpopulation at a 1:4 E:T ratio with the number of Gagspecific CD8 ϩ T cells that produced IFN-␥, TNF-␣, or both IFN-␥ and TNF-␣ for ES (Fig. 5A) and CP (Fig. 5B) . For each of the 4 memory subpopulations and bulk CD8 ϩ T cells, no statistically significant correlations between viral inhibition at day 3 of infection and the percentage of CD8 ϩ T cells that expressed cytokines in response to Gag stimulation was observed for either ES or CP. These data suggest that the inhibition of viral replication is not simply a function of the fraction of Gag-specific CD8
ϩ T cells present.
CD8 ؉ T cells with an HLA-DR ؊ CD38
؉ phenotype are significantly less effective at suppressing viral replication. Markers of CD8 ϩ T cell activation have also been intensely studied in HIV-1 infection (8, 20, 33) . Therefore, we determined which CD8 ϩ T cell subsets defined by activation marker expression were most effective at mediating the suppression of viral replication in ϩ T cells were stained with anti-CCR7 and anti-CD45 RA antibodies, and the expression of these markers was analyzed and quantified on day 5 after infection (n ϭ 5). The percentage of the CD8 ϩ T cells expressing markers indicative of a TE (light blue bars), EM (orange bars), naïve (red bars), or CM (purple bars) phenotype is indicated for each ES analyzed.
ES. A strategy similar to the memory subtype analysis was utilized. CD8 ϩ T cells and CD4 ϩ T cells were isolated directly ex vivo from PBMCs from ES and CP. All cells were maintained in nonstimulating medium for the duration of the experiment. The CD8 ϩ T cells were stained using anti-HLA-DR and anti-CD38 antibodies and sorted using fluorescence-activated cell sorting into DR
, and DR Ϫ CD38 ϩ activation subpopulations. The unstimulated, sorted CD8 ϩ T cells were cocultured at various E:T ratios with freshly isolated, autologous, target CD4 ϩ T cells that had been isolated directly ex vivo and infected with replication-competent NL4-3 ⌬Nef/GFP virus by spinoculation. The E:T ratio ranged from 1:1 to 1:128. The average percent infection for infected targets alone was compared to the percent infection seen in the presence of CD8 ϩ T cells to calculate a normalized percent inhibition for each subpopulation at each E:T ratio (Fig. 1B) .
A dose-dependent relationship between the E:T ratio and the normalized percent inhibition was observed for all ES and CP analyzed (Fig. 6A) , while no response was seen for the CD8 ϩ T cells from the uninfected, healthy donor (data not shown). The normalized inhibition values at E:T ratios of 1:4 and 1:32 are shown in Fig. 6B for the ES. Overall, the inhibitory potentials of the activation subpopulations were similar, with the DR Ϫ CD38 ϩ population being the exception. This population had a significantly lower suppressive effect than the DR ϩ CD38 Ϫ and bulk CD8
ϩ T cells at a 1:4 E:T ratio at day 3 after infection. The DR ϩ CD38 Ϫ population had the highest median inhibition, but this difference was not significant at the 1:4 E:T ratio. At a 1:32 E:T ratio, a significant difference remained between the DR ϩ CD38 Ϫ cells and the DR Ϫ CD38 ϩ CD8 ϩ T cells. By day 5 after infection, the inhibitory effects of all of the activation populations were all approaching 100% (Fig. 6B) . At a 1:4 E:T ratio, there were no significant differences between the subpopulations. However, at a 1:32 ratio, the DR Ϫ CD38 ϩ CD8 ϩ T cells produced much less inhibition than did all other populations. The inhibitory potential of the DR Ϫ CD38 ϩ subset was significantly less than that of each of the other three activation subpopulations and bulk CD8 ϩ T cells, with a median inhibition below 10%. CD8
ϩ T cells expressing HLA-DR generally had a high inhibitory potential, but this was not statistically different from inhibition produced by DR Ϫ CD38 Ϫ CD8 ϩ T cells. It is interesting that at day 5 after infection, DR Ϫ CD38 ϩ CD8 T cells had an inhibition similar to that of the other activation populations at a 1:4 ratio, but the suppression of viral replication was lost at lower E:T ratios.
The HLA-DR Ϫ CD38 ϩ subpopulation of CD8 ϩ T cells also had the lowest inhibitory potential of CP cells at an E:T ratio of 1:4 at day 3 of infection ( Fig. 6C) . No significant difference in inhibition of viral replication was seen in the different subpopulations at an E:T ratio of 1:32.
DISCUSSION
It is clear that cellular immunity is paramount in the control of viral replication by ES. However, the mechanisms by which ES mediate this remarkable control are still unclear. An improved understanding of these mechanisms can aid in the development of an effective HIV-1 vaccine, which is desperately needed for the control of the HIV-1 pandemic. Herein, we present an in-depth in vitro analysis of the control of viral replication by CD8 ϩ T cells from 8 ES. After 3 days of infection and coculture, EM and TE CD8 ϩ T cells were the most effective at inhibiting viral replication, suggesting that these cells represent the CD8 ϩ T cell populations that respond most rapidly to HIV-1 infection. A recent study demonstrated early control of SIV replication in the macaque model of HIV-1 disease after monkeys were treated with a preventative vaccine that elicited an EM T cell response. In this study, the EM vaccine induced high-frequency anti-SIV EM CD8
ϩ T cell responses, resulting in either complete control or persistent control for up to 1 year after infection (22) . These data in combination with the data presented herein support a model in which an effective EM CD8 ϩ T cell response is crucial to long-term control of HIV-1 infection.
In ES, CM CD8 ϩ T cells showed less activity after 3 days of infection but demonstrated a remarkable increase in inhibition at all E:T ratios after 5 days of infection. This is consistent with studies in the lymphocytic choriomeningitis virus (LCMV) model that demonstrated that memory CD8 ϩ T cells required reactivation before they effectively controlled viral replication (12) . It is currently unclear if this increase in the normalized percent inhibition is mediated by cells with a CM phenotype or if CM CD8 ϩ T cells underwent differentiation and expansion. It is possible that EM or TE CD8 ϩ T cells are responsible for the increase in the suppressive capacity that is observed by 5 days after infection for the sorted CM cell population. This hypothesis is supported by data showing that by day 5, EM and TE CD8 ϩ T cells were the majority population in 3 out of 5 ES that were analyzed, whereas CM CD8 ϩ T cells were the majority population in only 1 of these ES.
It should be noted that we used a conservative sorting scheme that did not account for all CD8 ϩ T cells, and recent studies have suggested that CD8 ϩ T cells with HIV-1-inhibitory activity may have phenotypes different from those described here (18, 28) . Functional studies of virus-specific CD8 ϩ T cells have shown that the markers used in this study also do not perfectly distinguish between central and effector memory CD8 ϩ T cells, and there is some plasticity in the expression of surface markers depending on the activation state (15, 26, 39, 52, (54) (55) (56) . This may explain why bulk CD8 ϩ T cells from CP were more effective than any of the sorted subsets of cells at inhibiting viral replication.
In a prior study, a correlation between HIV-1 inhibition and HIV-1-specific MIP-1 beta and CD107 CD8 ϩ T cell responses was 
ϩ T cells were compared. Open circles indicate a normalized percent inhibition of 0. The median value of the normalized percent inhibition for each subpopulation is indicated (n ϭ 8). Only significant P values are indicated.
observed (18) . In the current study, there was no significant correlation between IFN-␥ and TNF-␣ HIV-specific CD8 ϩ T cell responses and the normalized percent inhibition of viral replication for each memory subtype, although coproduction of these cytokines has been associated with cytotoxic potential of CD8 ϩ T cells (31) . While our findings are limited by the fact that we focused on Gag-specific T cell responses, studies have suggested that the cytotoxic T lymphocyte (CTL) response is predominantly concentrated on Gag in ES (27, 45, 47, 48) . This finding agrees with previous studies demonstrating no correlation between the frequency of HIV-1-specific CD8 ϩ T cells and viral load in cohort studies (1, 4) . It has been previously been shown that qualitative differences in the HIV-1 CD8 ϩ T cell response may be linked to control of HIV-1 replication (2, 5, 17, 24, 36, 37) . Further support for this comes from the data presented here which show that EM and TE cells from ES were more effective at controlling viral replication than EM and TE subsets from CP, even though similar percentages of Gag-specific cells were present in these populations of cells.
Markers of cellular activation have also been intensely studied in HIV-1 infection, and cell activation has been associated with accelerated disease progression (8, 33, 34) . However, it is unclear how immune activation specifically impacts HIV-1-specific immunity, and little is known about the suppressive ability of CD8 ϩ T cells subpopulations expressing different activation markers. Interestingly, of the activation subpopulations defined by HLA-DR and CD38 staining, the HLA-DR Ϫ CD38 ϩ population had a markedly decreased suppressive capacity on both day 3 and day 5 after infection. It is noteworthy that in a prior study, HIVspecific CD8 ϩ T cells from viremic patients were shown to express high levels of CD38, whereas HIV-1-specific CTLs from ES expressed significantly lower levels of this marker (48) .
It is clear that CD8 ϩ T cells from ES show remarkable inhibition of viral replication. Many memory and activation cell subsets were able to mediate potent inhibition of viral replication after 3 and 5 days of viral infection, which is consistent with the results from a recent study of HIV-1 controllers with viral loads of Ͻ5,000 copies/ml in which CD8 ϩ T cells with multiple different phenotypes were shown to be capable of inhibiting viral replication (18) . Taken together, these data support a key role for the CD8 ϩ T cell response in the control of viral replication and provide a detailed analysis of an effective immune response to HIV-1 infection. The development of an effective HIV-1 vaccine should stimulate EM and TE CD8 ϩ T cell responses, which were shown to most consistently and most rapidly result in a decrease in viral replication. However, a potent CM response may also be needed to replenish these effector cells. Additionally, an HLA-DR ϩ CD8 ϩ T cell activation phenotype should be elicited, as this phenotype was more effective than CD8 ϩ T cells with the HLA-DR Ϫ CD38 ϩ CD8 ϩ T cell phenotype. In summary, while our study is limited by the relatively small number of patients we studied and the fact that all our ES were HLA-B*57 positive, the data presented here represent a novel application of the CD8 ϩ T cell suppression assay and represent the most physiological study of CD8 ϩ T cell activation and memory subsets to date. These data provide insight into an effective immune response against HIV-1 infection and could be used to guide the development of an effective vaccine.
